drugset / Trial / NCT01583543

Olaparib in Adults With Recurrent/Metastatic Ewing's Sarcoma

NCT01583543 ↗

Phase 2 Completed 12 enrolled Massachusetts General Hospital
NaSingle-groupOpen-labelTreatment

Summary

This research study is a Phase II clinical trial to test the efficacy of Olaparib in adult participants with recurrent/metastatic Ewing's Sarcoma following failure of prior chemotherapy.

Timeline

Start
2012-05
Primary completion
2014-01
Completion
2014-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Olaparib Small molecule 400 mg Oral

Indications